Measure ID: MIPS 501|Ophthalmology|2026 Performance Year

Acute Posterior Vitreous Detachment and Acute Vitreous Hemorrhage Appropriate

Percentage of patients with a diagnosis of acute posterior vitreous detachment (PVD) and acute vitreous hemorrhage in either eye who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks.

ProcessOphthalmologyGeriatrics

Last updated: January 15, 2026

⚙️

Measure Specification

Denominator (Eligible Population)

All patients regardless of age
ANDDiagnosis for PVD
ANDAcute PVD: M1337
ANDDiagnosis for vitreous hemorrhage
ANDAcute vitreous hemorrhage: M1333
ANDPatient encounters during the performance period
WITHOUTEncounters conducted via telehealth: M1426

Denominator Exclusions1

M1334Patients with a post-operative encounter of the eye with the acute PVD within 2 weeks before the initial encounter or 2 weeks after initial acute PVD encounter

Numerator

Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks.

Submission Codes (QDCs)

✓ Performance Met
M1336Patients who were appropriately evaluated during the initial exam AND were re-evaluated no later than 2 weeks
✗ Performance Not Met
M1332Patients who were not appropriately evaluated during the initial exam AND/OR who were not re-evaluated within 2 weeks

Denominator Exceptions

M1335Denominator Exception: Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)

🧮MIPS Score Simulator

Estimate only — actual CMS scoring may vary based on reporting method, data completeness, and annual rule updates.

%Benchmarks vary by collection type
💡 Tip: Enter your performance rate to compare MIPS points across all collection types. The same rate can score differently depending on how you submit.
VBCA Insights

💡Why This Measure Matters

When acute PVD occurs with vitreous hemorrhage (blood in the eye), the risk of retinal tears is even higher and requires more aggressive follow-up. Perform the same thorough initial dilated exam, but plan a follow-up within two weeks instead of eight—the shorter interval reflects the higher urgency. Blood in the vitreous can obscure tears, so close monitoring is essential. Document your findings clearly and give the patient clear instructions about symptoms that require immediate return.

📖Clinical Rationale

Retinal tears, if treated promptly, are less likely to result in detachment. Pigmented cells and hemorrhage in the setting of an acute PVD are associated with an increased risk of retinal tears, and these findings necessitate close follow-up examination to identify and treat any associated retinal tears. Prompt treatment will minimize the potential for complications such as retinal detachment and improve a patient’s quality of life.

📝Clinical Recommendations

This measure is based on clinical recommendations adapted from the AAO Preferred Practice Guidelines (AAO, 2019), which are excerpted below. The eye examination should include the following elements: Examination of the vitreous for hemorrhage, detachment, and pigmented cells Careful examination of the peripheral fundus using scleral depression There are no symptoms that can reliably distinguish between a PVD with or without an associated retinal break; therefore, a peripheral retinal examination is required.

The preferred method of evaluating patients for peripheral vitreoretinal pathology is to use an indirect ophthalmoscope combined with scleral depression. Many patients with retinal tears have blood and pigmented cells in the anterior vitreous. In fully dilated eyes, slit-lamp biomicroscopy with a mirrored contact lens or a condensing lens is an alternative method in fully dilated eyes instead of a scleral depressed indirect examination of the peripheral retina.

A spontaneous vitreous hemorrhage can be the presenting sign of PVD or may occur during the evolution of the PVD. Two-thirds of patients who present with associated vitreous hemorrhage were found to have at least one break. In this subgroup, one-third had more than one break and approximately 88% of the breaks occurred in the superior quadrants. If media opacity or patient cooperation precludes an adequate examination of the peripheral retina, B- scan ultrasonography should be performed to search for retinal tears, RRD, mass lesions, or other causes of vitreous hemorrhage.

Bilateral patching and/or elevation of the head while sleeping may be used when attempting to clear the vitreous hemorrhage. If no abnormalities are found, frequent follow-up examinations are recommended (i.e., every 1–2 weeks initially). Wide-field color photography can detect some peripheral retinal breaks but does not replace careful ophthalmoscopy and may be useful in patients not able to tolerate the exam.

Even if the vitreous hemorrhage is sufficiently dense to obscure the posterior pole, the peripheral retina frequently can be examined using indirect ophthalmoscopy and scleral depression. Patients who present with vitreous hemorrhage sufficient to obscure all retinal details and have a negative B-scan ultrasonographic evaluation should be followed closely.

When a retinal tear is suspected, repeat ultrasonographic examination should be performed within 1 to 2 weeks of the initial evaluation.

📋Implementation Notes

This measure contains one strata defined by a single submission criteria. This measure produces a single performance rate. For the purposes of MIPS implementation, this patient-process measure is submitted a minimum of once per patient during the performance period. The most advantageous quality data code will be used if the measure is submitted more than once.

Report this measure through VBCA

Our QCDR handles measure selection, data validation, and submission—so you can focus on clinical performance.

Learn About Our QCDR →
© 2025 ASRS. All Rights Reserved.